NCT07295951 A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia Status RECRUITING Phase PHASE1
NCT05521087 A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias Status WITHDRAWN Phase PHASE1
NCT02145039 Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases Status TERMINATED Phase NA
NCT02141828 A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene Status COMPLETED Phase PHASE1
NCT01919866 Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells Status UNKNOWN Phase PHASE1/PHASE2
NCT01826214 Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia Status COMPLETED Phase PHASE2
NCT01339988 Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) Status UNKNOWN Phase PHASE4